The possible advantage of hybrid closed-loop therapy (i.e., artificial pancreas) over sensor-augmented pump therapy in very young children with type 1 diabetes is unclear. In this multicenter, ...

LONDEX, LTD., 207 Anerley Road, London, S.E.20, have introduced a patented system (“Lectralevel”) of floatless liquid level control, designed for automatically pumping out, filling or maintaining the ...

June 30, 2010 (Orlando, Florida) — In patients with type 1 diabetes and poor glycemic control, the use of a sensor-augmented insulin pump significantly improved their glycated hemoglobin levels, ...